Medchem Source
Private Company
Funding information not available
Overview
Medchem Source is a US-based, private CRO offering custom synthesis and contract research services, primarily serving the small molecule drug discovery sector. The company operates through a hybrid model, with business development and project management based in Newcastle, WA, and R&D execution outsourced to state-of-the-art partner facilities in New Jersey and Bangalore, India. Its expertise spans heterocyclic compounds, natural products, peptides, amino acid derivatives, and pheromones, aiming to accelerate client R&D timelines. Led by an experienced medicinal chemist founder, the company focuses on building long-term client relationships through reliable service and confidentiality.
Technology Platform
Integrated service model leveraging a network of synthetic chemistry expertise in heterocyclic compounds, natural products, peptides, amino acid derivatives, and pheromones. Utilizes partner-owned state-of-the-art facilities in the US and India for execution.
Opportunities
Risk Factors
Competitive Landscape
Medchem Source competes in the fragmented contract chemistry services market against large global CROs (e.g., WuXi, Charles River), many mid-sized specialized chemistry shops, and low-cost laboratories in Asia. Its differentiation lies in its founder's direct medicinal chemistry experience, a hybrid US-India cost/quality model, and a focus on complex, niche synthetic challenges rather than high-volume routine work.